As I come to the end of my mentored K award, do I need to submit my follow-up R01 to the same IC that funded my K?

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

While there are advantages to submitting to the same IC, if the science fits elsewhere, pitch it to the IC to which it best aligns.

Typically, a mentored K award is meant to serve as a pathway to an R01. The usual path is that the K grantee submits their first R01 to the same Institute/Center (IC) that funded their K, ideally around year 4 or 5 of the 5-year mentored K grant. One advantage of submitting to the same IC is that you are known there. If you have been successful on the K thus far, and have a good relationship with your K program officer (PO), it can help position you for success on the R01.

For example, you can ask both the K and the R01 PO at your funding IC to advise you on the R01 submission, and the K PO can offer institute-specific advice and discuss your work with the appropriate R01 PO at their IC. In addition, when it comes time to discuss your R01 submission at the second-level review at Council, your K PO can speak up on your behalf.

That said, sometimes it makes sense to submit your R01 to a different IC than the one that funded your K. For example, your research may have taken you in a different direction and now the R01 project fits more logically into the portfolio of a different IC. In addition, you might have intentionally steered your K project toward another IC that you knew would have a better ESI R01 funding line. While it is not typical for a K grantee to submit their R01 to a different IC, I have certainly seen applicants do so successfully. Have an open and honest discussion with the R01 POs at both the IC that funded your K and any other ICs that might be a good fit scientifically. You could also ask your K grant PO for their advice.

Dr. Meg Bouvier

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015.

She’s recently worked with more than 25% of the nation’s highest-performing hospitals*, three of the top 10 cancer hospitals*, three of the top 16 medical schools for research*, and 8 NCI-Designated Cancer Centers.

Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*As recognized by the 2024/25 US News & World Report honor roll.

Categories:
Bouvier Grant Group logo white
Scroll to Top
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

Newsletter Popup